EUVIMEDEUVIMED entdecken
Crossref

Analysis of COVID-19 patient outcomes with molnupiravir treatment and the role of risk factors: a single-centre retrospective descriptive study

Ondrej Zahornacký, Štefan Porubčin, Alena Rovňáková, Pavol Jarčuška, Dária Semenovová, Paulína Kubalcová, Erik Dorko, Kvetoslava Rimárová

Central European Journal of Public Health · 2024

DOI: 10.21101/cejph.a8398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Central European Journal of Public Health, 2024. Verfasst von Ondrej Zahornacký und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectology and Travel Medicine, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic. Hauptthemen laut MEDLINE: COVID-19 Drug Treatment, Antiviral Agents, Hydroxylamines, Cytidine. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 Drug TreatmentAntiviral AgentsHydroxylaminesCytidineHumansRetrospective StudiesMaleFemaleRisk FactorsMiddle AgedAgedCOVID-19HospitalizationAdultSARS-CoV-2Treatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

COVID-19Slovakiacentremolnupiravirrisk factorssinglestudytreatment

Substanzen

molnupiravirAntiviral AgentsHydroxylaminesCytidine

Autor:innen und Institutionen

  • Department of Infectology and Travel Medicine, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic.
  • Department of Radiology, AGEL Hospital, Levoca, Slovak Republic.
  • Department of Public Health and Hygiene, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic.

Zitieren

APA

Zahornacký, O., Porubčin, Š., Rovňáková, A., Jarčuška, P., Semenovová, D., Kubalcová, P., Dorko, E., & Rimárová, K. (2024). Analysis of COVID-19 patient outcomes with molnupiravir treatment and the role of risk factors: a single-centre retrospective descriptive study. Central European Journal of Public Health. https://doi.org/10.21101/cejph.a8398

Vancouver

Zahornacký O, Porubčin Š, Rovňáková A, Jarčuška P, Semenovová D, Kubalcová P, et al. Analysis of COVID-19 patient outcomes with molnupiravir treatment and the role of risk factors: a single-centre retrospective descriptive study. Central European Journal of Public Health. 2024. doi:10.21101/cejph.a8398

BibTeX
@article{Zahornack2024,
  author = {Zahornacký, Ondrej and Porubčin, Štefan and Rovňáková, Alena and Jarčuška, Pavol and Semenovová, Dária and Kubalcová, Paulína and Dorko, Erik and Rimárová, Kvetoslava},
  title = {Analysis of COVID-19 patient outcomes with molnupiravir treatment and the role of risk factors: a single-centre retrospective descriptive study},
  journal = {Central European Journal of Public Health},
  year = {2024},
  doi = {10.21101/cejph.a8398}
}
Kostenlos starten →